Medical device manufacturer Boston Scientific has confirmed a cyberattack that is impairing its IT infrastructure and business applications worldwide.
Here are the key details regarding the incident.
The breach occurred on Tuesday, with public disclosure following on Wednesday. The company has not specified whether data was exfiltrated or if ransomware was deployed.
Order fulfillment and shipping systems are offline. The outage is restricting access to global IT systems and applications essential for daily operations, and Boston Scientific has not provided a timeline for full restoration.
The attack vector and threat actors remain unidentified. The company has not disclosed how the intrusion occurred, and no group has claimed responsibility.
The news triggered a sharp decline in share price. Shares dropped 5% to 6% following the announcement, compounding a year-to-date decline of nearly 50% driven by soft demand for the Watchman heart implant and a reduced profit outlook.
The full operational and financial impact is still being assessed. Boston Scientific has not yet determined whether the event will have a material effect on its business.
The company has enacted its incident response protocol and engaged external cybersecurity experts to investigate and contain the threat. It has filed a Form 8-K with the Securities and Exchange Commission and pledged to issue further updates via its website.
Boston Scientific joins a growing roster of medical device firms targeted this year. Similar significant incidents have affected Stryker, Medtronic, and Abbott in 2024.
Also Read
- Dolly Parton Passes Away; Newborns Perish in Pakistan Hospital Blaze; Employers Trim GLP-1 Drug Benefits
- Hormone Replacement Therapy Linked to Reduced Dementia Risk in Large-Scale UK Study
- Next-Generation Therapies for Genetic Cardiovascular Risk Factor Poised for Market Approval
- Rare Immune Cell Proliferates After Age 100, Dominating the Blood of Supercentenarians


